Geviti Inc — SEC Form D Filing

Geviti Inc filed an SEC Form D on September 15, 2026, reporting $1.61M raised in Other.

Form D filing details

Filing
SEC Form D
Filing date
September 15, 2026
Amount reported
$1.61M
Round stage
Seed because a $1.6 million equity raise is characteristic of an early-stage company scaling its initial product offering and expanding its clinical network.
Industry
Other
Website
https://www.geviti.com

What the company does

Securities: Equity. Exemption: Rule 506(b). Incorporated: DELAWARE

Problem

Traditional healthcare systems focus on reactive treatment of disease rather than proactive optimization of individual healthspan and vitality.

Solution

Geviti delivers a comprehensive telehealth platform offering at-home blood diagnostics, personalized biomarker analysis, and direct-to-consumer access to longevity therapies and custom supplements.

Why now

Consumers are increasingly taking control of their own health data amidst a cultural shift toward preventative wellness and the rapid normalization of specialized telehealth services.

Source: SEC EDGAR Form D filing